BioSpace News Archive

The University of Chicago is committed to supporting the rapid development of new technologies and life-saving therapeutics in the battle against the coronavirus pandemic.

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 16,291,952 of the Company’s ordinary shares, at a purchase price of $0.30690 per share, in a registered direct offering.

AIDS Healthcare Foundation praised the work of U.S. Representatives Lloyd Doggett and Rosa DeLauro for their demand for an accounting of how Gilead Sciences has used public funds to make private profit off government research for the development of remdesivir.

Avadel Pharmaceuticals plc announced that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 11, 2020, to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2020.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, announced the appointment of Noreen R. Henig, MD as its Chief Medical Officer.

Cara Therapeutics, Inc. announced that the Company will host a conference call and live audio webcast on Monday, May 11, 2020, at 4:30 p.m. ET to report first quarter 2020 financial results and provide a corporate update.

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, announced plans to report first quarter 2020 financial results on Monday, May 11, 2020, before market open.

Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, reported its results for the quarter ended March 31, 2020.

Neos Therapeutics, Inc., a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, announced that it will report its first quarter 2020 financial results at the closing of U.S. financial markets on Monday, May 11, 2020.

Brickell Biotech, Inc., a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced that it will report its first quarter 2020 financial results after the close of the U.S. financial markets on Wednesday, May 13, 2020.